You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Patent: 8,562,980


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,562,980
Title:Stable digestive enzyme compositions
Abstract: Compositions of the present invention, comprising at least one digestive enzyme (e.g., pancrelipase) are useful for treating or preventing disorders associated with digestive enzyme deficiencies. The compositions of the present invention can comprise a plurality of coated particles, each of which is comprised of a core coated with an enteric coating comprising at least one enteric polymer and 4-10% of at least one alkalinizing agent, or have moisture contents of about 3% or less, water activities of about 0.6 or less, or exhibit a loss of activity of no more than about 15% after six months of accelerated stability testing.
Inventor(s): Ortenzi; Giovanni (Monza, IT), Marconi; Marco (Cinisello Balsamo, IT), Mapelli; Luigi (Milan, IT)
Assignee: Aptalis Pharma Limited (Wicklow, IE)
Application Number:13/019,856
Patent Claims:see list of patent claims

Details for Patent 8,562,980

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. COTAZYM pancrelipase Capsule, Delayed Release 020580 12/09/1996 ⤷  Try a Trial 2027-02-20
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 04/30/2009 ⤷  Try a Trial 2027-02-20
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 06/10/2011 ⤷  Try a Trial 2027-02-20
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 03/14/2013 ⤷  Try a Trial 2027-02-20
Digestive Care, Inc. PERTZYE pancrelipase Capsule, Delayed Release 022175 05/17/2012 ⤷  Try a Trial 2027-02-20
Digestive Care, Inc. PERTZYE pancrelipase Capsule, Delayed Release 022175 10/06/2016 ⤷  Try a Trial 2027-02-20
Digestive Care, Inc. PERTZYE pancrelipase Capsule, Delayed Release 022175 07/13/2017 ⤷  Try a Trial 2027-02-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 8,562,980

Country Patent Number Estimated Expiration
South Africa 200905630 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 2008102264 ⤷  Try a Trial
United States of America 8562981 ⤷  Try a Trial
United States of America 8562979 ⤷  Try a Trial
United States of America 8562978 ⤷  Try a Trial
United States of America 8293229 ⤷  Try a Trial
United States of America 8246950 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.